However, the LCSG trial showed a threefold increase in local recurrence and a slightly significant decrease in overall survival (OS) following sublobar resection.
← all excerpts
What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist.
1
—
—